...
首页> 外文期刊>Therapeutic delivery >New and novel approaches for enhancing the oral absorption and bioavailability of protein and peptides therapeutics
【24h】

New and novel approaches for enhancing the oral absorption and bioavailability of protein and peptides therapeutics

机译:提高蛋白质和肽治疗剂的口腔吸收和生物利用度的新的和新方法

获取原文
获取原文并翻译 | 示例
           

摘要

The advancement of the oral route for macromolecules has gained a lot of attention due to its noninvasive nature, safe and challenging in active research but with limited success. Oral administration poses challenges due to poor solubility, short half-life, quick elimination and the physical, chemical and biological barriers of the gastrointestinal tract. Approaches of past for improving oral absorption, such as enhancers, mucoadhesive delivery and enzyme inhibitors have been taken over by novel approaches like advanced liposomes, self-nanoemulsifying drug delivery system, nanoparticles and targeted delivery. Eudratech (TM) Pep, Peptelligence, Rani Pill and Pharm Film are the emerging technologies for delivering oral proteins and peptide. Calcitonin, semaglutide and octreotide are the peptides available in the market for oral delivery as outcomes of these technologies.
机译:大分子口服途径的进展因其无创性、安全性和在活跃研究中的挑战性而备受关注,但成功率有限。口服给药由于溶解性差、半衰期短、消除快以及胃肠道的物理、化学和生物屏障而面临挑战。过去改善口服吸收的方法,如促进剂、粘液粘附剂和酶抑制剂,已被先进的脂质体、自纳米乳化药物递送系统、纳米颗粒和靶向递送等新方法取代。Eudratech(TM)Pep、Peptelligence、Rani药丸和Pharm薄膜是口服蛋白质和肽的新兴技术。降钙素、塞马鲁肽和奥曲肽是这些技术的产物,市场上可用于口服的肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号